Howard M. Schneider
Profile
Mr. Howard M.
Schneider is a Director at Aris Industries, Inc. He is on the Board of Directors at Aris Industries, Inc.
Mr. Schneider was previously employed as Independent Director by Novelos Therapeutics, Inc.
He received his undergraduate degree from Harvard University and an MBA from New York University.
Former positions of Howard M. Schneider
Companies | Position | End |
---|---|---|
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | Director/Board Member | 2014-02-11 |
Aris Industries, Inc.
Aris Industries, Inc. Apparel/FootwearConsumer Non-Durables Aris Industries, Inc. engages in licensed trademarks. The firm's licensed products are sold primarily to department and specialty stores and national retail chains. The company was founded in 1947 and is headquartered in New York, NY. | Director/Board Member | - |
Training of Howard M. Schneider
Harvard University | Undergraduate Degree |
New York University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Aris Industries, Inc.
Aris Industries, Inc. Apparel/FootwearConsumer Non-Durables Aris Industries, Inc. engages in licensed trademarks. The firm's licensed products are sold primarily to department and specialty stores and national retail chains. The company was founded in 1947 and is headquartered in New York, NY. | Consumer Non-Durables |
Novelos Therapeutics, Inc.
Novelos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelos Therapeutics, Inc. is a pharmaceutical company, which is engaged in the development of novel drugs for the treatment and diagnosis of cancer. It comprises of three cancer-targeted compounds: GLOW2, HOT and LIGHT, which are used for the treatment of cancer. Its therapeutic compounds directly kill cancer cells while minimizing harm to normal cells. This offers the potential for a paradigm shift in cancer therapy by providing efficacy in all three major drivers of mortality in cancer: primary tumors, metastases and stem cell-based relapse. Its LIGHT compound is a small-molecule cancer-targeted imaging agent, which is potential for selective detection of tumors and metastases in a broad range of cancers. Its HOT compound is a small-molecule, broad-spectrum, cancer-targeted molecular radio therapeutic that delivers radiation directly and selectively to cancer cells and cancer stem cells. Its GLOW2 compound is a small-molecule, broad-spectrum, cancer-targeted, non-radioactive optical imaging agent which is potential for intraoperative tumor margin illumination and non-invasive tumor imaging. The company was founded on June 21, 1996 and is headquartered in Madison, WI. | Health Technology |
- Stock Market
- Insiders
- Howard M. Schneider